Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | JAB-23E73 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on JAB-23E73, a putative pan-KRAS inhibitor (May 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| JAB-23E73 | JAB 23E73|JAB23E73 | KRAS Inhibitor 30 | Limited information is currently available on JAB-23E73, a putative pan-KRAS inhibitor (May 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT06973564 | Phase Ib/II | JAB-23E73 | JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration | Recruiting | USA | 0 |